Latest news
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeatMarketBeat · Mon, 10 Aug 2026 06:27:33 GMTDimensional Fund Advisors LP Boosts Holdings in Oric Pharmaceuticals, Inc. $ORIC - MarketBeatMarketBeat · Sat, 08 Aug 2026 07:36:09 GMTOric Pharmaceuticals (NASDAQ:ORIC) Trading 12.3% Higher - Here's What Happened - MarketBeatMarketBeat · Tue, 04 Aug 2026 18:19:26 GMTStock Traders Purchase High Volume of Put Options on Oric Pharmaceuticals (NASDAQ:ORIC) - MarketBeatMarketBeat · Tue, 04 Aug 2026 17:37:40 GMTOric Pharmaceuticals (ORIC) Projected to Release Earnings on Tuesday - MarketBeatMarketBeat · Tue, 04 Aug 2026 16:58:07 GMTOric Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 5.2% - Should You Sell? - MarketBeatMarketBeat · Mon, 03 Aug 2026 19:35:14 GMTDefilade Capital Management L.P. Purchases Shares of 842,928 Oric Pharmaceuticals, Inc. $ORIC - MarketBeatMarketBeat · Mon, 03 Aug 2026 08:28:58 GMTVivo Capital LLC Cuts Stake in Oric Pharmaceuticals, Inc. $ORIC - MarketBeatMarketBeat · Fri, 31 Jul 2026 07:00:00 GMT